EP3694645A1 - Dispositif comportant une première chambre pour la réception d'un fluide corporel - Google Patents
Dispositif comportant une première chambre pour la réception d'un fluide corporelInfo
- Publication number
- EP3694645A1 EP3694645A1 EP18793575.4A EP18793575A EP3694645A1 EP 3694645 A1 EP3694645 A1 EP 3694645A1 EP 18793575 A EP18793575 A EP 18793575A EP 3694645 A1 EP3694645 A1 EP 3694645A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- chamber
- body fluid
- guide
- wall
- centrifugation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000001124 body fluid Anatomy 0.000 title claims abstract description 86
- 239000010839 body fluid Substances 0.000 title claims abstract description 85
- 238000012546 transfer Methods 0.000 claims abstract description 25
- 238000005119 centrifugation Methods 0.000 claims description 51
- 230000004888 barrier function Effects 0.000 claims description 36
- 238000011049 filling Methods 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 25
- 238000000926 separation method Methods 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 11
- 230000000903 blocking effect Effects 0.000 claims description 10
- 210000004369 blood Anatomy 0.000 description 32
- 239000008280 blood Substances 0.000 description 32
- 239000012530 fluid Substances 0.000 description 12
- 238000006073 displacement reaction Methods 0.000 description 11
- 238000011534 incubation Methods 0.000 description 11
- 239000000306 component Substances 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 7
- 238000007789 sealing Methods 0.000 description 7
- 229940088623 biologically active substance Drugs 0.000 description 6
- 238000011109 contamination Methods 0.000 description 6
- 210000002381 plasma Anatomy 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 239000000654 additive Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 210000001772 blood platelet Anatomy 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 239000012503 blood component Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 239000000565 sealant Substances 0.000 description 4
- 102000000589 Interleukin-1 Human genes 0.000 description 3
- 108010002352 Interleukin-1 Proteins 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000000035 biogenic effect Effects 0.000 description 2
- 239000002981 blocking agent Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 238000012432 intermediate storage Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 101001076407 Homo sapiens Interleukin-1 receptor antagonist protein Proteins 0.000 description 1
- 229940119178 Interleukin 1 receptor antagonist Drugs 0.000 description 1
- 102000051628 Interleukin-1 receptor antagonist Human genes 0.000 description 1
- 239000006004 Quartz sand Substances 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 239000010431 corundum Substances 0.000 description 1
- 229910052593 corundum Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- -1 for example Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003407 interleukin 1 receptor blocking agent Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/029—Separating blood components present in distinct layers in a container, not otherwise provided for
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5021—Test tubes specially adapted for centrifugation purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/02—Adapting objects or devices to another
- B01L2200/026—Fluid interfacing between devices or objects, e.g. connectors, inlet details
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0621—Control of the sequence of chambers filled or emptied
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/041—Connecting closures to device or container
- B01L2300/044—Connecting closures to device or container pierceable, e.g. films, membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/04—Closures and closing means
- B01L2300/041—Connecting closures to device or container
- B01L2300/045—Connecting closures to device or container whereby the whole cover is slidable
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0672—Integrated piercing tool
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0832—Geometry, shape and general structure cylindrical, tube shaped
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/087—Multiple sequential chambers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0409—Moving fluids with specific forces or mechanical means specific forces centrifugal forces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0478—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure pistons
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Anesthesiology (AREA)
- Pathology (AREA)
- Cardiology (AREA)
- External Artificial Organs (AREA)
- Centrifugal Separators (AREA)
- Air Bags (AREA)
- Massaging Devices (AREA)
Abstract
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL18793575T PL3694645T3 (pl) | 2017-10-11 | 2018-10-10 | Urządzenie z pierwszą i drugą komorą do przyjmowania płynu ustrojowego |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17195982.8A EP3470142A1 (fr) | 2017-10-11 | 2017-10-11 | Dispositif doté d'une première chambre permettant de recevoir un liquide biologique |
| PCT/EP2018/077574 WO2019072903A1 (fr) | 2017-10-11 | 2018-10-10 | Dispositif comportant une première chambre pour la réception d'un fluide corporel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3694645A1 true EP3694645A1 (fr) | 2020-08-19 |
| EP3694645B1 EP3694645B1 (fr) | 2021-12-01 |
Family
ID=60119852
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP17195982.8A Pending EP3470142A1 (fr) | 2017-10-11 | 2017-10-11 | Dispositif doté d'une première chambre permettant de recevoir un liquide biologique |
| EP18793575.4A Active EP3694645B1 (fr) | 2017-10-11 | 2018-10-10 | Dispositif comportant une première et une deuxième chambre pour la réception d'un fluide corporel |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP17195982.8A Pending EP3470142A1 (fr) | 2017-10-11 | 2017-10-11 | Dispositif doté d'une première chambre permettant de recevoir un liquide biologique |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11896972B2 (fr) |
| EP (2) | EP3470142A1 (fr) |
| JP (1) | JP7303185B2 (fr) |
| KR (1) | KR20200064093A (fr) |
| CN (1) | CN111278563B (fr) |
| AU (1) | AU2018348719B2 (fr) |
| BR (1) | BR112020006199A2 (fr) |
| CA (1) | CA3097515A1 (fr) |
| ES (1) | ES2907935T3 (fr) |
| IL (1) | IL273577A (fr) |
| MX (1) | MX2020003432A (fr) |
| PL (1) | PL3694645T3 (fr) |
| WO (1) | WO2019072903A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3830301A1 (fr) * | 2018-08-01 | 2021-06-09 | Mammoth Biosciences, Inc. | Compositions de nucléase programmable et leurs méthodes d'utilisation |
| WO2020142754A2 (fr) | 2019-01-04 | 2020-07-09 | Mammoth Biosciences, Inc. | Améliorations de nucléase programmable ainsi que compositions et méthodes d'amplification et de détection d'acide nucléique |
| DE102019206126A1 (de) * | 2019-04-29 | 2020-10-29 | B. Braun Melsungen Aktiengesellschaft | Medizinische Fluidübertragungsvorrichtung |
| DE102019217908A1 (de) * | 2019-11-20 | 2021-05-20 | B. Braun Melsungen Aktiengesellschaft | Medizinische Fluidübertragungsvorrichtung |
| KR102365747B1 (ko) * | 2019-12-23 | 2022-02-22 | (주)글로핀 | 원심분리기용 목표물질 추출키트 및 이를 이용한 목표물질 추출방법 |
| AT523531B1 (de) * | 2020-05-05 | 2021-09-15 | Univ Wien Med | Vorrichtung zum Verbinden einer Kanüle mit einem Behältnis |
| CN111974475B (zh) * | 2020-08-20 | 2021-09-21 | 四川行之智汇知识产权运营有限公司 | 血液成分分离器 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU39422A1 (fr) | 1960-11-16 | |||
| US3706305A (en) | 1971-03-03 | 1972-12-19 | Harold J Berger | Combination blood sampling vacuum syringe centrifuge container and specimen cup |
| US4209488A (en) * | 1978-10-10 | 1980-06-24 | Owens-Illinois, Inc. | Fluid collection apparatus |
| US4644807A (en) * | 1985-02-21 | 1987-02-24 | Dionex Corporation | Fluid sample delivery apparatus |
| US4828716A (en) | 1987-04-03 | 1989-05-09 | Andronic Devices, Ltd. | Apparatus and method for separating phases of blood |
| US5360011A (en) * | 1993-07-13 | 1994-11-01 | Mccallister Teresa D | Blood sample collection |
| ZA948564B (en) | 1993-11-19 | 1995-07-26 | Bristol Myers Squibb Co | Liquid separation apparatus and method |
| DE19903876B4 (de) | 1999-02-01 | 2006-09-28 | Orthogen Gentechnologie Gmbh | Verfahren zur in-vitro-Bildung und Anreicherung von Interleukin-1 Rezeptor-Antagonisten |
| US6398972B1 (en) | 1999-04-12 | 2002-06-04 | Harvest Technologies Corporation | Method for producing platelet rich plasma and/or platelet concentrate |
| US20030205538A1 (en) | 2002-05-03 | 2003-11-06 | Randel Dorian | Methods and apparatus for isolating platelets from blood |
| ES2349749T3 (es) | 2004-12-21 | 2011-01-11 | BECTON, DICKINSON & COMPANY | Conjunto de jeringuilla que tiene un mecanismo de inutilización. |
| US8052969B2 (en) * | 2006-12-28 | 2011-11-08 | Arthrex, Inc. | Method of making plasma enriched with platelets using a double syringe system where the second sytringe is within the first syringe and use thereof |
| DE102007056759A1 (de) | 2007-11-23 | 2009-05-28 | Roderfeld, Enno, Dr. | Blutentnahmevorrichtung |
| DE102008023545A1 (de) | 2008-05-14 | 2009-11-19 | Roderfeld Und Bora Gmbh & Co.Kg | Vorrichtung zur Herstellung einer biologisch aktiven Substanz |
| EP2352533B1 (fr) | 2008-12-01 | 2018-01-10 | General Electric Company | Système et procédé pour séparer des cellules nucleés de liquides biologiques |
| JP5691581B2 (ja) | 2011-02-04 | 2015-04-01 | ニプロ株式会社 | 多血小板血漿分離キット及び多血小板血漿分離方法 |
| WO2012154257A1 (fr) | 2011-02-17 | 2012-11-15 | Prometheus Laboratories Inc. | Appareil et procédé pour l'isolement de leucocytes et de cellules tumorales par filtration |
| BR112013022656B1 (pt) | 2011-03-11 | 2021-06-22 | Fenwal, Inc | Sistema de coleta de sangue automático de passagem única |
| WO2014168409A1 (fr) | 2013-04-11 | 2014-10-16 | (주)굿모닝바이오 | Récipient pour séparation du sang permettant d'extraire les plaquettes en vue d'une auto-transfusion |
-
2017
- 2017-10-11 EP EP17195982.8A patent/EP3470142A1/fr active Pending
-
2018
- 2018-10-10 KR KR1020207010997A patent/KR20200064093A/ko active IP Right Grant
- 2018-10-10 PL PL18793575T patent/PL3694645T3/pl unknown
- 2018-10-10 EP EP18793575.4A patent/EP3694645B1/fr active Active
- 2018-10-10 JP JP2020518475A patent/JP7303185B2/ja active Active
- 2018-10-10 CA CA3097515A patent/CA3097515A1/fr active Pending
- 2018-10-10 BR BR112020006199-9A patent/BR112020006199A2/pt active Search and Examination
- 2018-10-10 AU AU2018348719A patent/AU2018348719B2/en active Active
- 2018-10-10 CN CN201880064397.7A patent/CN111278563B/zh active Active
- 2018-10-10 US US16/652,620 patent/US11896972B2/en active Active
- 2018-10-10 ES ES18793575T patent/ES2907935T3/es active Active
- 2018-10-10 MX MX2020003432A patent/MX2020003432A/es unknown
- 2018-10-10 WO PCT/EP2018/077574 patent/WO2019072903A1/fr active Search and Examination
-
2020
- 2020-03-24 IL IL273577A patent/IL273577A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3694645B1 (fr) | 2021-12-01 |
| CN111278563A (zh) | 2020-06-12 |
| JP7303185B2 (ja) | 2023-07-04 |
| EP3470142A1 (fr) | 2019-04-17 |
| KR20200064093A (ko) | 2020-06-05 |
| US11896972B2 (en) | 2024-02-13 |
| PL3694645T3 (pl) | 2022-04-19 |
| US20200238274A1 (en) | 2020-07-30 |
| AU2018348719A1 (en) | 2020-04-16 |
| CN111278563B (zh) | 2022-12-20 |
| RU2020114945A (ru) | 2021-11-12 |
| MX2020003432A (es) | 2020-07-29 |
| BR112020006199A2 (pt) | 2020-10-13 |
| AU2018348719B2 (en) | 2023-07-27 |
| CA3097515A1 (fr) | 2019-04-18 |
| ES2907935T3 (es) | 2022-04-27 |
| WO2019072903A1 (fr) | 2019-04-18 |
| IL273577A (en) | 2020-05-31 |
| JP2020536604A (ja) | 2020-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3694645B1 (fr) | Dispositif comportant une première et une deuxième chambre pour la réception d'un fluide corporel | |
| DE102010003223B4 (de) | Vorrichtung zum Einsetzen in einen Rotor einer Zentrifuge, Zentrifuge und Verfahren zum fluidischen Koppeln von Kavitäten | |
| DE69930192T2 (de) | Vorrichtung und Verfahren zur Trennung von Bestandteilen einer flüssigen Probe | |
| EP2292334B1 (fr) | Centrifugeuse destinée à séparer du sang, récipients à communication fluidique correspondants, ainsi que procédé de production de concentré de thrombocytes hautement enrichis à partir de sang | |
| DE69912785T2 (de) | Vorrichtung zur filtration und extraktion und methode für ihre verwendung | |
| EP3120929B1 (fr) | Soupape d'admission pour systemes de chambres et recipients a echantillons ainsi que systemes de chambres dotes de recipients a echantillons dotes de telles soupapes d'admission | |
| EP2413138B1 (fr) | Dispositif et procédé de séparation de composants d'un liquide d'échantillon | |
| EP1919625B1 (fr) | Dispositif et procede de separation de particules magnetiques d'un liquide | |
| DE2308485A1 (de) | Vorrichtung zum trennen von fluessigen gemischen, insbesondere blut, in ihre bestandteile | |
| DE2711731A1 (de) | Fluid -sammelvorrichtung | |
| WO2003019131A2 (fr) | Procede et dispositif de preparation d'un prelevement d'origine biologique pour determiner au moins un constituants | |
| DE10134913A1 (de) | Vorrichtung und Verfahren zur Blutpräparation | |
| EP0734767A2 (fr) | Récepient pour le traitement à contamination réduite de liquides | |
| EP2647433B1 (fr) | Pièce d'insertion de flacon de réactif et flacon de réactif | |
| EP3778027B1 (fr) | Séparateur et procédé de séparation du plasma sanguin et des cellules sanguines | |
| DE102015203779A1 (de) | Vorrichtung zur automatisierten Prozessierung von Flüssigkeiten | |
| WO2020234218A1 (fr) | Système d'analyse microfluidique pour l'analyse d'échantillons de sang | |
| EP3990179B1 (fr) | Bouchon de fermeture pour fermer un tube pour prélèvement destiné à recevoir un liquide | |
| DE102016123658B4 (de) | Filtrationsvorrichtung und Verfahren zur Anreicherung von Targets und der nachfolgenden Freisetzung biogener Agenzien | |
| EP2926906A1 (fr) | Dispositif de soupape et dispositif de manipulation de liquides | |
| DE2717963C2 (de) | Einrichtung zur Aufbereitung von Probeflüssigkeiten, insbesondere zur Feststellung pathogener Mikroben in Körperflüssigkeiten | |
| DE102011122579A1 (de) | Verfahren zum Trennen von Suspensions- oder Kolloidbestandteilen und Vorrichtung zum Trennen von Suspensions- oder Kolloidbestandteilen | |
| WO2023061630A1 (fr) | Dispositif, en particulier cartouche microfluidique, et procédé, comprenant une chambre de prélèvement et un couvercle amovible | |
| DE102019213313A1 (de) | Zentrifugeneinheit für eine mikrofluidische Vorrichtung zur Prozessierung von flüssigen Proben | |
| WO2007054159A1 (fr) | Dispositif destine a l'obtention de suspensions cellulaires avec incorporation ulterieure d'additifs et procede associe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20200511 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61M 1/36 20060101ALI20210408BHEP Ipc: A61M 1/02 20060101ALI20210408BHEP Ipc: B01L 3/00 20060101AFI20210408BHEP |
|
| INTG | Intention to grant announced |
Effective date: 20210512 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1451251 Country of ref document: AT Kind code of ref document: T Effective date: 20211215 Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502018008065 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PK Free format text: BERICHTIGUNGEN |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2907935 Country of ref document: ES Kind code of ref document: T3 Effective date: 20220427 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220301 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220301 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220302 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220401 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502018008065 Country of ref document: DE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220401 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 |
|
| 26N | No opposition filed |
Effective date: 20220902 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221010 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PL Payment date: 20230928 Year of fee payment: 6 Ref country code: NL Payment date: 20231023 Year of fee payment: 6 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20231025 Year of fee payment: 6 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20231117 Year of fee payment: 6 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: TR Payment date: 20231003 Year of fee payment: 6 Ref country code: IT Payment date: 20231031 Year of fee payment: 6 Ref country code: IE Payment date: 20231019 Year of fee payment: 6 Ref country code: FR Payment date: 20231023 Year of fee payment: 6 Ref country code: DE Payment date: 20231120 Year of fee payment: 6 Ref country code: CH Payment date: 20231102 Year of fee payment: 6 Ref country code: AT Payment date: 20231019 Year of fee payment: 6 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20231023 Year of fee payment: 6 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211201 |